# Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

> **NCT02375581** · PHASE2 · UNKNOWN · sponsor: **First People's Hospital of Hangzhou** · enrollment: 130 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Icotinib
- **RADIATION:** Thoracic radiotherapy

## Key facts

- **NCT ID:** NCT02375581
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2016-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02375581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02375581, "Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02375581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*